ACCESS Newswire

AGFA HealthCare

Share
AGFA HealthCare Demonstrates How Enterprise Imaging Enables 'Imaging Without Barriers' at UKIO 2024

AGFA HealthCare's Enterprise Imaging advancements and innovations enhance the delivery of patient care and promote clinician wellbeing by increasing the efficiency of radiologists' workflow

MORTSEL, BELGIUM / ACCESSWIRE / May 8, 2024 / AGFA HealthCare's Enterprise Imaging Platform offers near-real-time access to images, powerful diagnostic and Artificial Intelligence tools, smart workflows that enable seamless sharing between sites, enhanced collaboration and more. Radiologists can increase their productivity and wellbeing while focusing on what's most important - diagnosing and treating patients, and a "life in flow."

To view this piece of content from cdn.nwe.io, please give your consent at the top of this page.

At UKIO 2024, AGFA HealthCare will demonstrate how its commitment to delivering "any image anywhere, any time" increases the day-to-day performance and job satisfaction of radiologists, radiographers and clinical teams. By harnessing the power of today's technology, AGFA HealthCare Enterprise Imaging creates a unified Imaging Health Record™ (IHR) that supports healthcare institutions to achieve their organisational goals, enabling clinical collaboration to support the patient pathway and empowering radiologists to meet their daily challenges.

"In today's world, enabling patient and clinician wellbeing depends on finding the ‘sweet spot' where patient care and technology intersect. By empowering radiologists and radiographers with tools and workflows that cut through the noise, we help them stay focused on patient care and making confident diagnoses, while supporting their own work/life balance. Our vision is to provide innovative technology that feels like an extension of their thought processes, bringing them to that moment at work when distractions fade away, they are at one with the technology, and everything just works," says Roberto Anello, Regional President for Northern Europe at AGFA HealthCare.

Enhanced productivity and wellbeing

At UKIO 2024, visitors can discover how the right solutions can help redefine the radiologist's flow by increasing the efficiency of their workflow, enhancing their productivity, and boosting the value of their work:

  • The power of Streaming: The explosion in medical imaging data requires solutions that make critical information readily available, regardless of location and time. Web-based streaming technology makes images available in seconds, wherever they are needed. Radiologists break free from geographical constraints, and all members of the care team are empowered to collaborate seamlessly.
  • Leveraging the benefits of Cloud: Enterprise Imaging Cloud seamlessly closes the image management infrastructure gap, delivering a Software-as-a-Service (SaaS) solution that is secure, scalable, and accessible; easy to maintain and use; at a predictable cost.
  • Teach & Research and Peer Learning: Carefully crafted modules let you turn the radiology department into a continuous learning environment that plays its role in facilitating scientific research, clinical trials, collaboration with AI vendors and more.
  • RUBEE® AI packages: AGFA HealthCare's expanded portfolio of curated AI packages demonstrates the power of embedding AI into Enterprise Imaging workflows. Discover how our customers are leveraging these innovations in their daily practice and becoming more productive.
  • Connecting partners in healthcare: Enterprise Imaging Cloud facilitates the creation of an Imaging Health Network™ (IHN), which makes images available to all members of the care team, at all times, no matter where they are located, including on compatible mobile devices.
  • Don't forget to engage with our Subject Matter Experts during the event. We are offering a series of insight sessions at our booth, all led by our regional Enterprise Imaging pioneers.
  • "Novel Methods for Image Access and Workflow Sharing across UK Imaging Networks" will be presented by Paige Miller, Pre-Sales Consultant.
  • "A novel Peer Learning tool to support and supervise clinical reporters; REALM and Candour as part of good radiology service governance" will be delivered by Dr. Nick Spencer, Chief Clinical Information Officer.
  • "New Technology for Image Distribution and Reporting" will be hosted by Lee Storey, Support & Managed Services Manager.

Session timings will be announced in the coming weeks - bookmark our News section to be kept up to date on more information.

Reach out to us at UKIO 2024 to see how to bring flow to your health organization - June 10-12, 2024, ACC Liverpool, booth #B23

About AGFA HealthCare

At AGFA HealthCare, we are transforming the delivery of care - supporting healthcare professionals across the globe with secure, effective, and sustainable imaging data management. As a company, we are dedicated to our customers, and we have harnessed a value framework of Mission, Vision and Customer Delivery Principles into our routine operations. Through these principles, we commit a consistent high-yield code of conduct to our associates - channelling our experience and aspirations to all of our stakeholders. Our Empowerer profile supports our focus on creating an exceptional experience through the power of technology and is an integral foundation to our company standards. AGFA HealthCare is a division of the Agfa-Gevaert Group. For more information on AGFA HealthCare, please visit www.agfahealthcare.com and follow us on LinkedIn.

AGFA and the Agfa rhombus are registered trademarks of Agfa-Gevaert N.V. Belgium or its affiliates. Imaging Health Network is a trademark and RUBEE is a registered trademark of AGFA HealthCare N.V. All rights reserved. All information contained herein is intended for guidance purposes only, and the characteristics of the products and services described in this publication can be changed at any time without notice. Products and services may not be available for your local area. Please contact your local sales representative for availability information. AGFA HealthCare diligently strives to provide as accurate information as possible but shall not be responsible for any typographical error.

Contact Information:

Buse Kayar
buse.kayar@issuerdirect.com

SOURCE: AGFA Healthcare

To view this piece of content from stats.nwe.io, please give your consent at the top of this page.

View the original press release on newswire.com.

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESS Newswire

DK

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

SK tes Launches New Circular IT Facility in Shannon, Expanding Ireland’s Role in Global Sustainable Tech Services24.4.2025 09:30:00 CEST | Press release

SHANNON, IE / ACCESS Newswire / April 24, 2025 / SK tes, a global leader in sustainable IT asset disposition (ITAD) and technology lifecycle services, has announced plans to open a new 36,000 square foot purpose-built facility in Shannon, marking a major vote of confidence in Ireland's thriving data and technology sector. The new facility will deliver comprehensive ITAD, data center decommissioning, and technology lifecycle management services to some of Ireland's largest enterprises, including hyperscale data center operators, while supporting national sustainability and circular economy goals. It will also create over 25 skilled jobs in one of the country's fastest-growing tech regions. "Ireland is at the forefront of Europe's digital economy, and our investment in Shannon reinforces our commitment to helping Irish companies manage technology securely, sustainably, and at scale," said Eric Ingebretsen, Chief Commercial Officer at SK tes. "This facility will allow us to meet the uniqu

Sauce Labs Launches Industry-First Enterprise Scale iOS 18 Testing on Sauce Labs Virtual Device Cloud, Boosting Test Speeds up to 40%24.4.2025 08:00:00 CEST | Press release

Leading test automation platform, powering development for over 300,000 active users and having executed more than 8 billion tests, enables developers and QA teams to ensure app quality on Apple's latest OS with unprecedented performance and scale. SAN FRANCISCO, CA / ACCESS Newswire / April 24, 2025 / Sauce Labs Inc., the leading platform for continuous quality, trusted by dev teams around the world to deliver apps users love, today announced the general availability of iOS 18 testing on its Virtual Device Cloud (VDC). Leveraging its new, high-performance Apple Silicon cloud infrastructure, Sauce Labs offers the market's most scalable enterprise-ready solution for automated mobile app and web testing on iOS 17.5, iOS 18, and beyond, enabling teams to execute tests up to 40% faster compared to previous versions. This launch addresses the critical need for timely testing support driven by Apple's transition to its proprietary Apple Silicon architecture and the rapid adoption rate of new

Introducing NUGEN(R) HLD-CD by Arxada: A Game-Changer in Healthcare Disinfection24.4.2025 07:00:00 CEST | Press release

Delivering Effective Germ Control in Five Minutes BASEL, CH / ACCESS Newswire / April 24, 2025 / Arxada, a global leader in specialty chemicals and innovative solutions, announces the launch of NUGEN® HLD-CD, a revolutionary healthcare disinfectant. This game-changing solution disinfects medical devices in just five minutes, ensuring that even the most resilient microorganisms, which can withstand harsh conditions, are destroyed.* NUGEN® HLD-CD is designed to meet the rigorous demands of healthcare environments. Its broad efficacy spectrum and short contact times make it suitable for all critical areas, including operating rooms, isolation areas, and intensive care units where speed and safety are essential. "We are excited to introduce NUGEN® HLD-CD to the healthcare market," said Uwe Holland, Head of Professional Hygiene EMEA at Arxada. "This solution is a game-changer in disinfection technology for healthcare facilities, providing professionals with a powerful means to improve patie

TCL Introduces the TCL T6C-UK Fire TV Series with QLED 4K, HDR PRO, and Freely23.4.2025 07:30:00 CEST | Press release

LONDON, UNITED KINGDOM / ACCESS Newswire / April 23, 2025 / TCL, the leading consumer electronics brand and the world's second-largest TV brand as well as an official sponsor of the Olympic Games, is proud to announce the launch of its highly anticipated T6C-UK TV series. The new range offers screen sizes from 43" to 85", ensuring there is a perfect option for every home. Featuring QLED technology, 4K resolution, and an intuitive Fire TV experience, the T6C-UK series offers exceptional picture quality, seamless content access, and smart functionality. The TCL T6C-UK series comes Freely-enabled, offering a seamless way to enjoy live and on-demand TV - all in one place and completely free. With Freely built-in, users can access their favourite streaming apps at the click of a button, eliminating the need to switch between platforms. From major channels to must-watch shows, everything is easily accessible from a single, intuitive home screen. Powered by Fire TV, the T6C-UK series also fea

BioNxt Solutions Prepares for Human Bioequivalence Study For MS23.4.2025 03:05:00 CEST | Press release

VANCOUVER, BC / ACCESS Newswire / April 23, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to report advanced preparation for its human bioequivalence study for its lead Multiple Sclerosis (MS) treatment. BioNxt's lead product, BNT23001, is a proprietary sublingual thin-film formulation of Cladribine for the treatment of MS. Preclinical studies, as reported in internal research data and third-party evaluations, have demonstrated high absorption rates and bioequivalence compared to existing oral tablet therapies. The Company has purchased Cladribine active pharmaceutical ingredient which is necessary to complete the technology transfer process with Gen-Plus, its European Contract Research and Development Organization (CRDO), in Munich, Germany. Once commenced, the bioequivalence study is relatively short, scheduled for less than 30 days from start to finish. T

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye